TRIM37 and ovarian cancer: The MTT assay and colony formation assay both demonstrated that overexpression of TRIM37 decreases the sensitivity of ovarian cancer cells to olaparib, whereas knockdown of TRIM37 exerts the opposite effect (Fig. S4).